Lv5
1315 积分 2020-10-11 加入
Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18
1个月前
已完结
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
1个月前
已完结
Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study
1个月前
已完结
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial
1个月前
已完结
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week
1个月前
已完结
Vericiguat for heart failure and the VICTORIA trial - the dog that didn't bark?
1个月前
已完结
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
1个月前
已完结
Risk Profiles in Heart Failure
1个月前
已完结
The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
1个月前
已完结
Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory
1个月前
已完结
鄂公网安备 42011102003731号
